Lv1
78 积分 2024-01-10 加入
Nonalcoholic fatty liver disease: another leap forward
11小时前
已完结
Metabolic liver disease — what’s in a name?
11小时前
已完结
Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa
11小时前
已完结
From NAFLD to MAFLD: when pathophysiology succeeds
11小时前
已完结
A pivotal year for NAFLD and NASH therapeutics
11小时前
已完结
FGF-based drug discovery: advances and challenges
11小时前
已完结
From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research
11小时前
已完结
USP25 directly interacts with and deubiquitinates PPARα to increase PPARα stability in hepatocytes and attenuate high-fat diet-induced MASLD in mice
11小时前
已完结
A new treatment and updated clinical practice guidelines for MASLD
11小时前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
11小时前
已完结
皖公网安备34019202002308
